BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24766278)

  • 1. 'Neuroendocrine' middle ear adenomas: consistent expression of the transcription factor ISL1 further supports their neuroendocrine derivation.
    Agaimy A; Lell M; Schaller T; Märkl B; Hornung J
    Histopathology; 2015 Jan; 66(2):182-91. PubMed ID: 24766278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature.
    Torske KR; Thompson LD
    Mod Pathol; 2002 May; 15(5):543-55. PubMed ID: 12011260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Middle ear adenoma. A cytologically uniform neoplasm displaying a variety of architectural patterns.
    Mills SE; Fechner RE
    Am J Surg Pathol; 1984 Sep; 8(9):677-85. PubMed ID: 6476196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Middle ear adenoma: clinical and pathologic analysis].
    Bai Y; Yue C; Yang D; Han Y; Zhang Y; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):900-4. PubMed ID: 26888509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle ear adenoma with neuroendocrine differentiation (MEA-ND) in the pediatric population.
    Dogru S; Wilkinson EP; Robinson RA; Smith RJ
    Int J Pediatr Otorhinolaryngol; 2009 Jun; 73(6):895-8. PubMed ID: 19303146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Middle ear adenoma with neuroendocrine differentiation : A pediatric case report.
    Sterrer E; Windisch F; Frey K; Rettensteiner K; Loader B
    Wien Klin Wochenschr; 2017 Mar; 129(5-6):208-211. PubMed ID: 27761737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases.
    Schmitt AM; Riniker F; Anlauf M; Schmid S; Soltermann A; Moch H; Heitz PU; Klöppel G; Komminoth P; Perren A
    Am J Surg Pathol; 2008 Mar; 32(3):420-5. PubMed ID: 18300808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of TTF1, CDX2 and ISL1 in 74 poorly differentiated neuroendocrine carcinomas.
    Lee H; Fu Z; Koo BH; Sheehan CE; Young GQ; Lin J; Patil DT; Yang Z
    Ann Diagn Pathol; 2018 Dec; 37():30-34. PubMed ID: 30236546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine adenoma of the middle ear.
    Cruz Toro P; Domenech I; Clemente I; Farré A; Amilibia E
    Otol Neurotol; 2012 Jan; 33(1):e7-8. PubMed ID: 21527867
    [No Abstract]   [Full Text] [Related]  

  • 10. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors.
    Zhao LH; Chen C; Mao CY; Xiao H; Fu P; Xiao HL; Wang G
    Pathol Res Pract; 2019 Jul; 215(7):152448. PubMed ID: 31133441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Middle ear adenoma. A tumor displaying mucinous and neuroendocrine differentiation.
    Wassef M; Kanavaros P; Polivka M; Nemeth J; Monteil JP; Frachet B; Tran Ba Huy P
    Am J Surg Pathol; 1989 Oct; 13(10):838-47. PubMed ID: 2782545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinoid tumor of the middle ear. Morphology, immunohistochemistry, clinical aspects and differential diagnosis].
    Ruck P; Pfisterer EM; Kaiserling E
    Laryngorhinootologie; 1990 Feb; 69(2):74-6. PubMed ID: 2322359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine adenoma of the middle ear with extension into the external auditory canal.
    Kacerovska D; Cermak J; Kreuzberg B; Kazakov D
    Cesk Patol; 2012 Jan; 48(1):36-8. PubMed ID: 22716008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Middle ear adenoma: a case report].
    Namysłowski G; Scierski W; Lange D
    Otolaryngol Pol; 2001; 55(2):207-10. PubMed ID: 11494741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine adenoma of the middle ear (NAME).
    Leong K; Haber MM; Divi V; Sataloff RT
    Ear Nose Throat J; 2009 Apr; 88(4):874-9. PubMed ID: 19358129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Middle ear adenoma/carcinoid tumour: a case report and review of the literature.
    Angouridakis N; Hytiroglou P; Markou K; Bouzakis A; Vital V
    Rev Laryngol Otol Rhinol (Bord); 2009; 130(3):199-202. PubMed ID: 20345079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Middle ear adenoma/middle ear carcinoid--an unproblematic tumor?].
    Strehl MA; Scheich M; Ott I; Müller-Hermelink HK; Hagen R; Völker HU
    Laryngorhinootologie; 2009 Mar; 88(3):186-90. PubMed ID: 19065497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amphicrine adenoma of the middle ear. Histological, immunohistochemical and ultrastructural study of a case].
    Wassef M; Kanavaros P; Nemeth J; Adjamagbo H; Ba Huy PT
    Ann Pathol; 1993; 13(3):170-5. PubMed ID: 7691060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Middle-ear adenoma (MEA): a report of two cases, one with predominant "plasmacytoid' features.
    Ribé A; Fernández PL; Ostertarg H; Clarós P; Bombí JA; Palacín A; Cardesa A
    Histopathology; 1997 Apr; 30(4):359-64. PubMed ID: 9147085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Middle ear adenomatous tumor with a predominant neuroendocrine component.
    Paraskevakou H; Lazaris AC; Kandiloros DC; Papadimitriou K; Adamopoulos G; Davaris PS
    Pathology; 1999 Aug; 31(3):284-7. PubMed ID: 10503278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.